March 25, 2020 / 12:34 PM / 10 days ago

BRIEF-Vir Biotechnology Proceeding With Two Clinical Development Candidates For COVID-19

March 25 (Reuters) - Vir Biotechnology Inc:

* VIR BIOTECHNOLOGY PROCEEDING WITH TWO CLINICAL DEVELOPMENT CANDIDATES FOR COVID-19

* VIR BIOTECHNOLOGY INC - MULTIPLE ANTIBODIES IDENTIFIED THAT NEUTRALIZE SARS-COV-2

* VIR BIOTECHNOLOGY INC - PHASE 1/2 CLINICAL TESTING PLANNED FOR THIS SUMMER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below